SHIRLEY SIMMONS: Open Payments
NPI 1386678035 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 18 payments from 8 companies in 2025. Trend: 2023 $870 · 2024 $936 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $39 |
| CSL Behring | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $16 |
Products named: NUCALA, FASENRA, NEFFY, XOLAIR, NEMLUVIO, DUPIXENT, TRELEGY ELLIPTA, Hizentra.
Industry payments across WV — which companies pay providers there.
